Skip to content

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05489068
Enrollment
150
Registered
2022-08-05
Start date
2022-03-16
Completion date
2026-12-01
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance-Related Disorders, Treatment Adherence

Brief summary

This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.

Interventions

BEHAVIORALMotivational Interviewing at Intake (MII)

The MII will involve a goal-oriented and collaborative conversation about why the client wants treatment now, and how treatment might fit with his/her most important values. The provider will use open questions, reflective listening and autonomy support in a flexible, non-authoritative manner. Rather than asking specific questions in different life domains, the provider will explore with the client their desires, abilities, reasons, and needs for treatment, how treatment fits with their values, and what successful treatment looks like to them. The client's language about change will be strategically reinforced to increase its frequency and strength across the session.

BEHAVIORALIntake as Usual (IAU)

In line with the American Society of Addiction Medicine (ASAM) guidelines, the IAU condition involves a semi-structured interview of the client's psychosocial history and clients answer a series of questions in the following domains: support system, living situation, educational, occupational, family, and medical history.

Sponsors

University of New Mexico
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Effectiveness-Implementation Hybrid Type 1 Design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(client participants): * English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures * Physically withdrawn from alcohol or other drugs Inclusion Criteria (personnel participants): * English-speaking adults currently employed at one of the two outpatient addiction treatment programs * Provision of electronic informed consent

Exclusion criteria

(client participants): * Experiencing severe withdrawal symptoms * Actively psychotic, manic, and/or suicidal

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who attended the first outpatient treatment program session based on electronic medical record reviewup to 36 weeksTreatment entry is determined by review of electronic medical record of whether clients attended their first scheduled treatment session
Number of treatment sessions attended during the three-month outpatient treatment program based on electronic medical record reviewup to 36 weeksNumber of treatment sessions that clients attend is determined by review of electronic medical record and calculating number of treatment sessions attended.
Number of participants who completed the three-month outpatient treatment program based on electronic medical record reviewup to 36 weeksCompletion of the three-month outpatient treatment program is determined by review of electronic medical record

Secondary

MeasureTime frameDescription
Change from baseline in client readiness to enter treatment on the University of Rhode Island Change Assessment Scale (URICA) at 1 hour post-intakebaseline and 1 hour post-intakeThe URICA is a validated, self-report measure of client readiness for treatment engagement. Possible scores range from 32 to 160 with higher scores indicative greater readiness to enter treatment. Change = (Hour 1 score - Baseline Score).
Score on therapeutic alliance on the Working Alliance Inventory (WAI) at 1-hour post-intake1 hour post-intakeThe WAI is a validated, self-report measure of client perceptions of the therapeutic process by assessing three sub scales: Goals, Bond, and Tasks. Possible scores on sub scales range from 12 to 84 with higher scores indicative of better therapeutic alliance.

Countries

United States

Contacts

CONTACTMargo Hurlocker, PhD
mhurlocker@unm.edu(505) 596-0578
PRINCIPAL_INVESTIGATORMargo Hurlocker, PhD

University of New Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026